Procardia Xl(Nifedipine)
PFE
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Pfizer Inc.
$979K
Medicare cost, 2024
$979K
Medicare cost, 2024
Medicare drug plans spent $978,592 on Procardia Xl (nifedipine) in 2024, for 1,214 prescriptions and refills filled by 396 patients. Spending fell 51% from 2023 to 2024. New York accounts for the most spending ($168,830, 17% of the total). It is made by Pfizer Inc. (PFE).
Medicare cost, 2024
$979K
-51.2% from 2023
Prescriptions
1,214
$806.09 per claim
Patients
396
469 prescribers
Total spending, 2024
$979K
$2,471.19 per patient
Questions and answers
How much does Medicare spend on Procardia Xl?
Medicare prescription drug plans paid $979K for Procardia Xl in 2024, for 1,214 prescriptions and refills to 396 patients (down 51.2% from 2023). The average cost per claim was $806.09.
Which state spends the most on Procardia Xl?
New York had the highest Medicare cost for Procardia Xl in 2024: $169K for 197 claims, followed by California ($110K).
Who prescribes Procardia Xl the most?
Ramon Rivera-Morales, family practice in Miami, FL, had the highest Medicare cost for Procardia Xl in 2024: 12 claims costing $4,997.
Who makes Procardia Xl?
Procardia Xl is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Procardia Xl was $979K in 2024, after a high of $3.0M in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Procardia Xl, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Ramon Rivera-Morales Miami, FL | Family Practice | 12 | Under 11 | $4,997 |
| Alexander Bangiev Rego Park, NY | Nephrology | 17 | Under 11 | $4,238 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 874 | 3,065 | 728 | $2.2M |
| 2023 | 790 | 2,767 | 652 | $2.0M |
| 2024 | 469 | 1,214 | 396 | $979K |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm | 1,214 | $979K |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 5
- Application numbers
- NDA019684
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 41,738 side-effect reports named nifedipine, the active ingredient of Procardia Xl (reports from 2001 on). 33,154 of them (79.4%) were serious, 4,823 named a death and 17,626 named a hospital stay. The reactions named most often were drug ineffective, dyspnoea and diarrhoea. 13,376 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
41,738
2,734 in 2025 (-7.8% from 2024)
Serious
79.4%
33,154 reports
Deaths named
4,823
11.6% of reports
Hospital stays
17,626
42.2% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
Since 2002. 2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Procardia Xl?
41,738 reports from 2001 through September 2026 named nifedipine, the active ingredient of Procardia Xl. 33,154 of them (79.4%) were serious, 4,823 named a death and 17,626 named a hospital stay.
What are the most reported side effects of Procardia Xl?
2,351 reports named drug ineffective, the reaction named most often, followed by dyspnoea (2,198) and diarrhoea (2,149). In the last 5 years the reaction named most often was off label use (1,011 reports). A report can name several reactions.
How many side-effect reports named Procardia Xl in 2025?
2,734 reports were received in 2025 (-7.8% from 2024). 2026 so far: 2,030 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Procardia Xl caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Procardia Xl caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with nifedipine: Nifedipine Er, Nifedipine
- Makers on the stock market:
PFE·PFE drug pipeline - Drug approvals (17 approvals on file for nifedipine) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (nifedipine) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.